Brazil researchers report disappointing 50.4% efficacy for CoronaVac vaccine

A coronavirus vaccine developed by China’s Sinovac showed “general efficacy” of 50.4% in a late-stage trial in Brazil, researchers said, barely enough for regulatory approval and far short of earlier indications. The latest results are a major disappointment for Brazil, as the Chinese vaccine is one of two that the federal government has lined up to begin immunisation during the second wave of the world’s second-deadliest COVID-19 outbreak.

Source: Reuters

Solar sector will gain about 5,400 new companies in 2021

The solar energy sector is experiencing exponential growth in Brazil, with a rate of about 450 new companies per month in the country, according to mapping of the Solar Portal. The perspective is to arrive at the end of the year with approximately 5,400 companies entering the national photovoltaic market, which will correspond to a growth of 27% in the current volume.

Source: Canal Energia